Medical Devices
Medical Imaging Devices Market Size, 2024-2033
USD Billion
The figures are in the full report. Request a free sample ↗
Market overview
| Study Period | 2024 - 2033 |
|---|---|
| Historic Year | 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 - 2033 |
| Market Size (Base Year) | USD 60.0 Billion |
| Market Size (Forecast Year) | USD 85.3 Billion |
| Growth Rate (CAGR) | 4.5 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | High |
Pages from the sample report. Figures are shown as XX here; the full report has them.
See the full sample: Request a free sample ↗
Medical imaging devices are the machines that let doctors see inside the body without surgery, including CT scanners, MRI systems, X-ray and mammography units, ultrasound systems, molecular imaging scanners such as PET/CT, and the imaging systems used to guide procedures in the operating room and the catheter lab.
This report covers the sale of these systems to hospitals, imaging centres and clinics, together with the service contracts and software that keep them running. A few large makers supply most of the world's scanners, and each installed system is typically serviced and upgraded for many years, so the installed base and its replacement cycle shape demand as much as new hospitals do. Contrast agents, radiotherapy machines and stand-alone hospital IT systems are outside the scope.
Demand for imaging grows with ageing populations and with the spread of cancer, heart disease and neurological conditions, which are diagnosed and monitored with CT, MRI, PET/CT and ultrasound. Health systems are also trying to diagnose earlier and in more places, which adds scanners in outpatient centres and smaller hospitals and portable ultrasound at the point of care.
Technology keeps the replacement cycle moving. Photon-counting CT, helium-light and wide-bore MRI, total-body and large-field PET/CT, and AI software that speeds up scanning and reading give hospitals reasons to upgrade, and makers increasingly sell systems with multi-year service and software agreements.
The main restraints are cost and budgets. Advanced scanners are expensive to buy, install and staff, and hospital capital spending swings with public budgets. In China, a large equipment-renewal programme lifted orders, but tender volumes and foreign makers' sales there fell back in 2025 and 2026 as centralized procurement and local makers gained ground, while a United States trade investigation into imported medical equipment has added uncertainty for makers and buyers.
The global Medical Imaging Devices market is mainly classified based on modality and offering. On the basis of modality, the market is segmented into CT and molecular imaging systems (CT, PET/CT and SPECT), MRI systems, X-ray and mammography systems, ultrasound systems, and interventional and surgical imaging systems (angiography and C-arms). Based on offering, the market is divided into equipment, services, and digital solutions and software.
CT and molecular imaging systems are expected to account for the largest share by modality, as CT is the workhorse of emergency and cancer imaging and PET/CT is growing with new tracers for cancer and Alzheimer's disease, followed closely by MRI and ultrasound. X-ray is the most widely installed modality but sells at lower prices and grows slowly. By offering, equipment accounts for the largest share, services provide a large and steady stream of revenue from the installed base, and digital solutions and AI software are the fastest-growing part of the market.
North America is expected to hold the largest share of the global market, led by the United States, which has a large installed base of CT, MRI and PET/CT systems, a dense network of outpatient imaging centres and early adoption of new technology such as photon-counting CT.
Europe is the second major market, where public health systems replace ageing scanners and invest in imaging to shorten waiting lists. Asia-Pacific is expected to be the fastest-growing region, as China, India and Southeast Asia add hospitals and scanners and local makers such as United Imaging and Mindray expand at home and abroad, although China's procurement cycle makes demand there uneven.
South America and the Middle East and Africa are smaller markets where demand is growing with private hospital investment and government health programmes, particularly in Brazil, the Gulf states and Saudi Arabia.
Some of the major competitors in the global Medical Imaging Devices market include GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shanghai United Imaging Healthcare Co., Ltd., FUJIFILM Holdings Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hologic, Inc., Samsung Medison Co., Ltd., Esaote S.p.A., Shimadzu Corporation, and Carestream Health, Inc.
The Medical Imaging Devices industry is highly concentrated, with the largest maker alone holding a large part of the market for CT, MRI, X-ray and molecular imaging. GE HealthCare, Siemens Healthineers and Philips lead worldwide, followed by Canon Medical Systems and United Imaging Healthcare, with Fujifilm, Mindray, Hologic, Samsung Medison, Esaote, Shimadzu and Carestream strong in particular modalities or regions. Companies compete on image quality, speed and dose, AI software, service coverage and price, and are strengthening their positions through new scanner launches, multi-year service and enterprise agreements, local manufacturing and expansion in emerging markets.
Ans: The Medical Imaging Devices market was valued at XX billion US$ in 2025 and is projected to reach YY billion US$ by 2033, at a CAGR of XX% during the forecast period.
Ans: Replacement of ageing scanners, photon-counting CT and new MRI and PET/CT systems, AI software, multi-year service agreements, portable and handheld ultrasound, and new capacity in Asia-Pacific, the Middle East and Latin America offer major opportunities.
Ans: The main driver is rising demand for diagnosis and monitoring from ageing populations and chronic disease, together with new imaging technology that encourages hospitals to upgrade.
Ans: North America is expected to have the largest share of the Medical Imaging Devices market, while Asia-Pacific is expected to grow fastest.
Ans: CT and molecular imaging systems are expected to dominate by modality and equipment by offering, while digital solutions and software are expected to grow fastest.
The conflict that began on 28 February 2026 affects medical imaging mainly through helium. Most MRI scanners use superconducting magnets cooled by liquid helium, for which there is no short-term substitute. Qatar, one of the largest helium producers in the world, halted production at its Ras Laffan complex in early March 2026 after attacks on its facilities, and its exports depend on the Strait of Hormuz, which remains largely blocked.
Helium prices on the open market have risen steeply, suppliers have put customers on allocation, and Qatar has said it will take years to bring the plant back to full operation. Hospitals compete for helium with much larger buyers such as chipmakers, so they face higher running costs for MRI and the risk of delays to scans where supplies run short.
For equipment makers, the conflict has so far been a matter of costs more than demand. In July 2026, GE HealthCare reported record orders while pointing to higher costs for oil, freight and memory chips and listing conflicts in the Middle East among its risks.
This report treats the conflict as a cost and supply risk for MRI rather than a change in the long-term need for imaging. The base year, 2025, is before the conflict, and the forecast follows the long-run trend. The helium shortage is likely to speed up demand for scanners that need little or no liquid helium, which the leading makers have been developing.
Backed by 1 million+ hours of research experience across the industries we cover.
Domains covered
Countries covered
Committed to timely delivery
Projects delivered